Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aminopterin in methotrexate-naive rheumatoid arthritis
NCT01724931Phase 2Completed
- Sponsor
- Syntrix Pharmaceuticals
- Start
- Feb 2013
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aminopterin in rheumatoid arthritis (RA), sponsored by Syntrix Pharmaceuticals. Started Feb 2013; status: completed.
02
Drugs
aminopterin
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01724931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01724931.